Immune Checkpoint Inhibitor‐Associated Myocarditis With Myositis/Myasthenia Gravis Overlap Syndrome: Two Case Reports Highlighting Early Onset, Diagnostic Uncertainty, and Management Considerations

ABSTRACT Immune checkpoint‐inhibitors (ICIs) have revolutionized and significantly improved cancer care through remarkable efficacy, but significant adverse effects have been observed. Among these, ICI‐induced myocarditis with myositis/myasthenia gravis overlap syndrome represents a life threatening...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Artur Schneider, Nikita Jhawar, Deepica Reddy, Razvan Chirila
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2026-01-01
Sarja:	Clinical Case Reports
Aiheet:	immune checkpoint inhibitor myasthenia gravis myocarditis myositis
Linkit:	https://doi.org/10.1002/ccr3.71763
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!